NEU

PLTRFRM00018

Pharmaceuticals

Market Closed - Warsaw S.E. Other stock markets 11:55:54 2024-05-22 EDT			5-day change	1st Jan Change
941 ^PLN	-0.95%		+0.21%	+1.73%

05-17	Neuca S.A. Announces Dividend, Payable on June 25, 2024	CI
03-23	NEUCA S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Neuca Provides Revenue Guidance for the Third Quarter of 2019

August 28, 2019 at 11:40 am

Neuca provided revenue guidance for the third quarter of 2019. The company expects its revenues to increase year on year in third quarter.

Latest news about NEUCA S.A.

Neuca S.A. Announces Dividend, Payable on June 25, 2024	05-17	CI
NEUCA S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	03-22	CI
NEUCA S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
NEUCA S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-29	CI
ODI Pharma’s Stock Soars After Exclusive Supplier Deal With Synoptis Pharma	23-08-07	MT
NEUCA S.A. acquired 51.26% stake in PPH Ewa Krotoszyn S.A for PLN 10.5 million.	23-07-19	CI
NEUCA S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Neuca Plans to Offer Dividend for 2022	23-03-28	CI
NEUCA S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-27	CI
NEUCA S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-16	CI
NEUCA S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-30	CI
NEUCA S.A.’s Equity Buyback announced on May 31, 2022, has expired.	22-06-07	CI
NEUCA S.A. announces an Equity Buyback for 95,000 shares, representing 2.13% for PLN 73.15 million.	22-05-31	CI
NEUCA S.A. authorizes a Buyback Plan.	22-05-30	CI
NEUCA S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-18	CI
NEUCA S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
NEUCA S.A.'s Equity Buyback announced on April 6, 2021, has expired.	21-12-30	CI
NEUCA S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-09	CI
NEUCA S.A. completed the acquisition of 32.82% stake in Pomerania investment Spolka Akcyjna.	21-09-28	CI
Neuca Reports Earnings Results for the Second Quarter of 2021	21-08-26	CI
Neuca Reports Earnings Results for the First Quarter 2021	21-05-13	CI
NEUCA S.A. commences an Equity Buyback Plan for 100,000 shares for PLN 90 million worth of its issued capital, under the authorization approved on February 3, 2021.	21-04-05	CI
Neuca S.A. Announces Earnings Results for the Fourth Quarter and Full Year 2020	21-03-25	CI
NEUCA S.A. Announces Resignation of Pawel Kusmierowski as Board Member	21-03-18	CI
NEUCA S.A. signed a preliminary conditional agreement to acquire 32.82% stake in Pomerania investment Spolka Akcyjna.	21-01-31	CI

Neuca SA is a Poland-based company, which operates in the healthcare market. The Company is mainly involved in the distribution of drugs to pharmacies. It also operates in other sectors of the health market, such as production of drugs, supplements and cosmetics under its own brand, clinical trials, telemedicine, Information Technology (IT) solutions and e-commerce in the health care industry.

Sector

Pharmaceuticals

Calendar

2024-05-22 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for NEUCA S.A.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

941 PLN

Average target price

974.7 PLN

Spread / Average Target

+3.58%

Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
NEUCA S.A.	+1.73%	1.07B
CARDINAL HEALTH, INC.	-4.44%	23.46B
SINOPHARM GROUP CO. LTD.	+5.38%	8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+7.83%	8.35B
HUADONG MEDICINE CO., LTD	-21.35%	7.88B
H. LUNDBECK A/S	+13.31%	5.21B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+10.84%	4.09B
EBOS GROUP LIMITED	-1.97%	4.11B
GALENICA AG	-2.34%	3.87B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+20.72%	3.6B

Pharmaceuticals Wholesale

NEUCA S.A.

Equities

NEU

PLTRFRM00018

Pharmaceuticals

Neuca Provides Revenue Guidance for the Third Quarter of 2019

Latest news about NEUCA S.A.

Chart NEUCA S.A.

Company Profile

Income Statement Evolution

Ratings for NEUCA S.A.

Analysts' Consensus

Quarterly revenue - Rate of surprise

Sector Pharmaceuticals Wholesale